AUG 14, 2026 · JOURNAL ARTICLE
Impact of antibiotic exposure on survival outcomes in NSCLC patients treated with third-generation EGFR-TKIs
BMC Cancer
A retrospective cohort study with propensity score matching showing a clear association between antibiotic exposure and worse survival in EGFR-mutated NSCLC, but limited by single-centre design, modest sample size, and observational methodology that cannot establish causation.
Reported
Median PFS antibiotic group16.2 months
Median PFS non-antibiotic group22.4 months
Median OS antibiotic group38.1 months